Brief: Amir Nashat reports 13.5% stake in CAMP4 Therapeutics
22/10/2024 23:01
Oct 22 (Reuters) - CAMP4 Therapeutics Corp CAMP.O :
* AMIR NASHAT REPORTS 13.5% STAKE IN CAMP4 THERAPEUTICS AS
OF OCT
15 - SEC FILING
Source text for Eikon: ID:n0001193125-24-241180
Further company coverage: CAMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CAMP4 Therapeutics
See all newsBrief: Camp4 Therapeutics Receives Authorization In The United Kingdom For Phase 1/2 Human Clinical Trial Of Cmp-002 In Patients With Syngap1-Related Disorder
Camp4 Therapeutics Corp Reports Results For The Quarter Ended June 30: Earnings Summary
Camp4 Therapeutics Q2 Loss Per Share Misses Estimates On Non: cash derivative charge
Camp4 Therapeutics Corp Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation